EFFETTI DELLA SUPPLEMENTAZIONE CON ACIDI GRASSI ω-3 (EPA + DHA) NELL'IPERTRIGLICERIDEMIA PRIMITIVA

Translated title of the contribution: Effects of omega 3 fatty acid supplementation in patients with primary hypertriglyceridemia

G. Perani, E. Maggi, C. Muggia, D. Covini, E. Gallanti, O. Catalano, G. Bellomo

Research output: Contribution to journalArticle

Abstract

In order to assess the overall impact of PUFA ω-3 supplementation on cardiovascular risk, the effects of such a supplementation on blood pressure, plasma lipoproteins and in vitro and in vivo LDL oxidizability have been evaluated in a group of patients with primary endogenous hypertriglyceridemia. After a period on a standard hypolipidemic diet, patients were randomly allocated to treatment with an individually-tailored diet either alone or supplemented with PUFA ω-3. PUFA ω-3 supplementation, but not diet alone, induced a significant reduction in diastolic blood pressure and plasma triglycerides, but was also associated with an enhanced susceptibility of LDL to in vitro oxidation. Moreover, the anti-oxidized LDL IgG autoantibody titer rose during treatment with PUFA ω-3, thus suggesting an increased LDL oxidation actually taking place in vivo. Although the effects on blood pressure and plasma triglycerides were admittedly favourable, the findings regarding LDL oxidizability are of some concern and suggest a cautious use of PUFA ω-3 supplementation in patients with primary hypertriglyceridemia, unless associated with antioxidants.

Original languageItalian
Pages (from-to)87-93
Number of pages7
JournalRivista Italiana di Biologia e Medicina
Volume15
Issue number3-4
Publication statusPublished - 1995

Fingerprint

Hypertriglyceridemia
Omega-3 Fatty Acids
Blood Pressure
Diet
Triglycerides
Autoantibodies
Lipoproteins
Antioxidants
Immunoglobulin G
Therapeutics
oxidized low density lipoprotein
In Vitro Techniques
low density lipoprotein inhibitor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

EFFETTI DELLA SUPPLEMENTAZIONE CON ACIDI GRASSI ω-3 (EPA + DHA) NELL'IPERTRIGLICERIDEMIA PRIMITIVA. / Perani, G.; Maggi, E.; Muggia, C.; Covini, D.; Gallanti, E.; Catalano, O.; Bellomo, G.

In: Rivista Italiana di Biologia e Medicina, Vol. 15, No. 3-4, 1995, p. 87-93.

Research output: Contribution to journalArticle

@article{ae73baecbecd488b9a10d3db63fda38d,
title = "EFFETTI DELLA SUPPLEMENTAZIONE CON ACIDI GRASSI ω-3 (EPA + DHA) NELL'IPERTRIGLICERIDEMIA PRIMITIVA",
abstract = "In order to assess the overall impact of PUFA ω-3 supplementation on cardiovascular risk, the effects of such a supplementation on blood pressure, plasma lipoproteins and in vitro and in vivo LDL oxidizability have been evaluated in a group of patients with primary endogenous hypertriglyceridemia. After a period on a standard hypolipidemic diet, patients were randomly allocated to treatment with an individually-tailored diet either alone or supplemented with PUFA ω-3. PUFA ω-3 supplementation, but not diet alone, induced a significant reduction in diastolic blood pressure and plasma triglycerides, but was also associated with an enhanced susceptibility of LDL to in vitro oxidation. Moreover, the anti-oxidized LDL IgG autoantibody titer rose during treatment with PUFA ω-3, thus suggesting an increased LDL oxidation actually taking place in vivo. Although the effects on blood pressure and plasma triglycerides were admittedly favourable, the findings regarding LDL oxidizability are of some concern and suggest a cautious use of PUFA ω-3 supplementation in patients with primary hypertriglyceridemia, unless associated with antioxidants.",
keywords = "polyunsaturated fatty acids, primary hypertriglyceridemia",
author = "G. Perani and E. Maggi and C. Muggia and D. Covini and E. Gallanti and O. Catalano and G. Bellomo",
year = "1995",
language = "Italian",
volume = "15",
pages = "87--93",
journal = "Rivista Italiana di Biologia e Medicina",
issn = "0393-1137",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3-4",

}

TY - JOUR

T1 - EFFETTI DELLA SUPPLEMENTAZIONE CON ACIDI GRASSI ω-3 (EPA + DHA) NELL'IPERTRIGLICERIDEMIA PRIMITIVA

AU - Perani, G.

AU - Maggi, E.

AU - Muggia, C.

AU - Covini, D.

AU - Gallanti, E.

AU - Catalano, O.

AU - Bellomo, G.

PY - 1995

Y1 - 1995

N2 - In order to assess the overall impact of PUFA ω-3 supplementation on cardiovascular risk, the effects of such a supplementation on blood pressure, plasma lipoproteins and in vitro and in vivo LDL oxidizability have been evaluated in a group of patients with primary endogenous hypertriglyceridemia. After a period on a standard hypolipidemic diet, patients were randomly allocated to treatment with an individually-tailored diet either alone or supplemented with PUFA ω-3. PUFA ω-3 supplementation, but not diet alone, induced a significant reduction in diastolic blood pressure and plasma triglycerides, but was also associated with an enhanced susceptibility of LDL to in vitro oxidation. Moreover, the anti-oxidized LDL IgG autoantibody titer rose during treatment with PUFA ω-3, thus suggesting an increased LDL oxidation actually taking place in vivo. Although the effects on blood pressure and plasma triglycerides were admittedly favourable, the findings regarding LDL oxidizability are of some concern and suggest a cautious use of PUFA ω-3 supplementation in patients with primary hypertriglyceridemia, unless associated with antioxidants.

AB - In order to assess the overall impact of PUFA ω-3 supplementation on cardiovascular risk, the effects of such a supplementation on blood pressure, plasma lipoproteins and in vitro and in vivo LDL oxidizability have been evaluated in a group of patients with primary endogenous hypertriglyceridemia. After a period on a standard hypolipidemic diet, patients were randomly allocated to treatment with an individually-tailored diet either alone or supplemented with PUFA ω-3. PUFA ω-3 supplementation, but not diet alone, induced a significant reduction in diastolic blood pressure and plasma triglycerides, but was also associated with an enhanced susceptibility of LDL to in vitro oxidation. Moreover, the anti-oxidized LDL IgG autoantibody titer rose during treatment with PUFA ω-3, thus suggesting an increased LDL oxidation actually taking place in vivo. Although the effects on blood pressure and plasma triglycerides were admittedly favourable, the findings regarding LDL oxidizability are of some concern and suggest a cautious use of PUFA ω-3 supplementation in patients with primary hypertriglyceridemia, unless associated with antioxidants.

KW - polyunsaturated fatty acids

KW - primary hypertriglyceridemia

UR - http://www.scopus.com/inward/record.url?scp=0029553771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029553771&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0029553771

VL - 15

SP - 87

EP - 93

JO - Rivista Italiana di Biologia e Medicina

JF - Rivista Italiana di Biologia e Medicina

SN - 0393-1137

IS - 3-4

ER -